Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-519908-27-01Phase 2Completed
Phase 2, open-label, single-arm trial of estradiol in anorexia nervosa (AN), sponsored by University Hospital of North Norway. Primary endpoints: Anxiety levels by STAI-C and Eating disorder symptoms by EDE-Q. Started Jan 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-519908-27-01.